US Patent Issued to DR. OREGONIN on Sept. 15 for "Composition for anti-obesity and preventing or treating muscle loss, containing catechin glycoside extract derived from plant in genus Ulmus as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,204, issued on Sept. 15, was assigned to DR. OREGONIN INC. (Chuncheon-si, South Korea).

"Composition for anti-obesity and preventing or treating muscle loss, containing catechin glycoside extract derived from plant in genus Ulmus as active ingredient" was invented by Sun Eun Choi (Chuncheon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a pharmaceutical composition for anti-obesity and preventing or treating muscle loss, which contains an extract of a plant in the genus Ulmus as an active ingredient."

The patent was filed on May 10, 2022, under Application No. 18/266,174.

*For further information, including images, cha...